KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Finished Goods: 2018-2024

Historic Finished Goods for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Dec 2024 value amounting to $5.0 million.

  • Rigel Pharmaceuticals' Finished Goods fell 69.37% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 69.37%. This contributed to the annual value of $5.0 million for FY2024, which is 232.49% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Finished Goods stood at $5.0 million for FY2024, which was up 232.49% from $1.5 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Finished Goods registered a high of $5.0 million during FY2024, and its lowest value of $449,000 during FY2020.
  • For the 3-year period, Rigel Pharmaceuticals' Finished Goods averaged around $2.8 million, with its median value being $1.9 million (2022).
  • Per our database at Business Quant, Rigel Pharmaceuticals' Finished Goods decreased by 20.80% in 2023 and then spiked by 232.49% in 2024.
  • Yearly analysis of 5 years shows Rigel Pharmaceuticals' Finished Goods stood at $449,000 in 2020, then surged by 192.20% to $1.3 million in 2021, then spiked by 45.12% to $1.9 million in 2022, then dropped by 20.80% to $1.5 million in 2023, then soared by 232.49% to $5.0 million in 2024.